Muscle spasm market is involuntary, sudden contraction of muscle or group of muscles of the body. Muscle spasm is also known as muscle cramp or involuntary hypertonicity. Muscle spasm usually occurs after muscular injury and is a sudden blast of high intensity pain, which ceases after five to ten minutes. Muscle spasm, in general condition, does not cause any chronic harm to the body. The most commonly affected muscles are lower leg muscles, front of the thigh and back of the thigh. Additionally, muscles of arms, feet, hands and abdomen are also affected, although the proportion is less.
The major causes of muscle spasm include muscular injury, spinal nerve compression, sprains and strains of the muscle (due to overuse) and diabetic ketoacidosis. Additionally, rickets, low blood potassium and sodium, animal instincts, and heat stroke are some of the other important causes of the condition. Since these cramps do not lead to any chronic condition, usually medical diagnosis and treatment is not advised. However, if the condition is persistent for longer period of time, a proper diagnosis is required. Blood test is a major diagnosis test (to understand thyroid functions, potassium and sodium levels) for muscle spasm. Additionally, electromyography is also performed to diagnose the disease.
Request Brochure of Muscle Spasm Market Report
The market of muscle spasm is segmented on the basis of drugs used to treat the condition, such as, diazepam, quinine, phenytoin, carbamazepine and others. Additionally, rehydration therapy, vitamin E, magnesium, calcium and niacin are also prescribed. The market is also segmented on the basis of geography, such as North America, Europe, Asia-Pacific and Rest of the World (RoW).The North American region is the most dominating market in the world, owing to large incidences of muscle spasm, and rising focus towards R&D for muscle spasm treatments. On the other hand, Asia Pacific and RoW are the most promising markets in the upcoming period, owing to rise in awareness of muscle spasm, its causes and effects and its treatments.
Some of the major players operating in this market include Amgen, Inc., Eisai Co., Ltd., Novartis International AG, GlaxoSmithKline plc, AstraZeneca plc, Pfizer, Inc., and F. Hoffmann La Roche Ltd. amongst others.